InfuSystem PE ratio INFU

Share price divided by earnings per share over the last twelve months, since 2013.

Today, Oct 23, 2026: 34.0×
10-year median: 43.5×
Against its 10-year history: 41st; percentile: 0 is its lowest day, 100 its highest
10-year range: 9.0× to 496×
Peer median: 20.7×

InfuSystem's PE ratio is 34.0× as of Oct 23, 2026: a share price of $13.94 against $0.41 of earnings per share over the last twelve months.

That is below its ten-year median of 43.5×, close to the middle of its last ten years.

Over that time it ranged from 9.0× in Nov 2016 to 496× in Sep 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 20.7×.

PE ratio over time

median 43.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	34.0×	22.1×	34.0×
2025	34.5×	34.2×	137×
2024	136×	136×	330×
2023	351×	286×	496×
2022	489×	19.2×	494×
2021	31.5×	18.4×	62.8×
2020	53.7×	39.6×	206×
2019	n/m a value too high to mean anything
2018	n/m a value too high to mean anything
2017	28.1×	26.3×	29.4×
2016	31.9×	9.0×	31.9×
2015	27.5×	17.6×	33.1×
2014	20.5×	18.1×	74.5×
2013	53.8×	41.0×	156×

Against its peers

Companies in Medical - Instruments & Supplies nearest InfuSystem's size, closest first, today.

Company	PE ratio
INFUInfuSystem	34.0×
UTMDUtah Medical Products	22.6×
EMBCEmbecta	4.6×
PDEXPro DEX	15.1×
TCMDTactile Systems Technology	21.9×
MDXGMimedx	97.8×
MOVMovado	17.5×
KEQUKewaunee Scientific	11.9×
IRMDIradimed	47.9×
STAAStaar Surgical	323×
BVSBioventus	19.4×
Peer median	20.7×

Where InfuSystem ranks

#22of 35Medical instruments and supplies stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on InfuSystem

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.